Literature DB >> 25845432

Expression of Tight Junction Components in Hepatocyte-Like Cells Differentiated from Human Embryonic Stem Cells.

Boglárka Erdélyi-Belle1, György Török, Ágota Apáti, Balázs Sarkadi, Zsuzsa Schaff, András Kiss, László Homolya.   

Abstract

Human embryonic stem cells can be differentiated in vitro into a wide variety of progeny cells by addition of different morphogens and growth factors. Our aim was to monitor the expression pattern of tight junction (TJ) components and various cellular markers during differentiation of stem cell lines toward the hepatic lineage. Human embryonic stem cell lines (HUES1, HUES9) were differentiated into endoderm-like cells, and further differentiated to hepatocyte-like cells. Gene expressions of Oct3/4, Nanog, alpha-fetoprotein, albumin, cytokeratins (CK-7, CK-8, CK-18, CK-19), ATP-binding cassette (ABC) transporters (ABCC2, ABCC7, ABCG2), and various TJ components, including claudin-1, claudin-4, claudin-5, claudin-7, and tricellulin, as well as an extracellular matrix component, agrin were monitored during hepatic differentiation by real-time quantitative PCR. The differentiated cells exhibit epithelial morphology and functional assessments similar to that of hepatocytes. The expression level of stem cell marker genes (Oct3/4 and Nanog) significantly and gradually decreased, while liver-associated genes (alpha-fetoprotein, albumin) reached their highest expression at the end of the differentiation. The endoderm-like cells expressed claudin-1, which declined eventually. The expression levels of cholangiocyte markers including claudin-4, CK-7, CK-19, and agrin gradually increased and reached their highest level at the final stage of differentiation. In contrast, these cells did not express notable level of claudin-7, CK-8 and tricellulin. The marker set used for monitoring differentiation revealed both hepatocyte and cholangiocyte characteristics of the differentiated cells at the final stage. This is the first report describing the expression level changes of various TJ components, and underlining their importance in hepatic differentiation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25845432     DOI: 10.1007/s12253-015-9936-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  71 in total

1.  Immunohistochemical classification of ductular reactions in human liver.

Authors:  Eszter Turányi; Katalin Dezsö; Judit Csomor; Zsuzsa Schaff; Sándor Paku; Péter Nagy
Journal:  Histopathology       Date:  2010-09-28       Impact factor: 5.087

2.  Architectural and immunohistochemical characterization of biliary ductules in normal human liver.

Authors:  Katalin Dezso; Sándor Paku; Veronika Papp; Eszter Turányi; Peter Nagy
Journal:  Stem Cells Dev       Date:  2009-12       Impact factor: 3.272

3.  Tight junctions: molecular structure meets function.

Authors:  Jörg-Dieter Schulzke; Michael Fromm
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

4.  Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro.

Authors:  Hossein Baharvand; Seyed M Hashemi; Saeid Kazemi Ashtiani; Ali Farrokhi
Journal:  Int J Dev Biol       Date:  2006       Impact factor: 2.203

5.  Tricellulin expression in normal and neoplastic human pancreas.

Authors:  Anna Korompay; Katalin Borka; Gábor Lotz; Aron Somorácz; Péter Törzsök; Boglárka Erdélyi-Belle; István Kenessey; Zsolt Baranyai; Fanni Zsoldos; Péter Kupcsulik; György Bodoky; Zsuzsa Schaff; András Kiss
Journal:  Histopathology       Date:  2012-03-06       Impact factor: 5.087

6.  Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions.

Authors:  Adrienn Bodo; Eva Bakos; Flora Szeri; Andras Varadi; Balazs Sarkadi
Journal:  J Biol Chem       Date:  2003-04-19       Impact factor: 5.157

7.  Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma.

Authors:  Gábor Sobel; Csilla Páska; István Szabó; András Kiss; Anna Kádár; Zsuzsa Schaff
Journal:  Hum Pathol       Date:  2005-02       Impact factor: 3.466

8.  Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers.

Authors:  Zsuzsanna Németh; Attila Marcell Szász; Péter Tátrai; Júlia Németh; Hajnalka Gyorffy; Aron Somorácz; Attila Szíjártó; Péter Kupcsulik; András Kiss; Zsuzsa Schaff
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

9.  Three-dimensional reconstructions of intrahepatic bile duct tubulogenesis in human liver.

Authors:  Peter S Vestentoft; Peter Jelnes; Branden M Hopkinson; Ben Vainer; Kjeld Møllgård; Bjørn Quistorff; Hanne C Bisgaard
Journal:  BMC Dev Biol       Date:  2011-09-26       Impact factor: 1.978

10.  Manner of interaction of heterogeneous claudin species within and between tight junction strands.

Authors:  M Furuse; H Sasaki; S Tsukita
Journal:  J Cell Biol       Date:  1999-11-15       Impact factor: 10.539

View more
  4 in total

Review 1.  Cellular Processing of the ABCG2 Transporter-Potential Effects on Gout and Drug Metabolism.

Authors:  Orsolya Mózner; Zsuzsa Bartos; Boglárka Zámbó; László Homolya; Tamás Hegedűs; Balázs Sarkadi
Journal:  Cells       Date:  2019-10-08       Impact factor: 6.600

2.  The importance of transporters and cell polarization for the evaluation of human stem cell-derived hepatic cells.

Authors:  György Török; Zsuzsa Erdei; Julianna Lilienberg; Ágota Apáti; László Homolya
Journal:  PLoS One       Date:  2020-01-23       Impact factor: 3.240

Review 3.  Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy.

Authors:  Saiprasad Gowrikumar; Amar B Singh; Punita Dhawan
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

Review 4.  Medically Important Alterations in Transport Function and Trafficking of ABCG2.

Authors:  László Homolya
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.